Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Econazole Nitrate Foam 1% vs Cream in Tinea Pedis
NCT00768599Phase 2Completed
- Sponsor
- AmDerma Pharmaceuticals
- Start
- Mar 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of econazole in tinea pedis (3 arms), sponsored by AmDerma Pharmaceuticals. Primary endpoints: Complete Cure Rate: Interdigital Disease at Day 43 and Complete Cure Rate: Moccasin Disease at Day 43. Started Mar 2008; status: completed.
02
Drugs
econazole
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT00768599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00768599.